HD
35
3
LYB
20
-9
EQR
50
-3
SBUX
44
3
EQT
65
8
SLG
45
-3
NSC
64
2
HOG
45
3
MOS
26
-3
GOOG
69
2
PFE
50
2
BLK
61
6
ETR
57
5
PFG
67
2
DE
48
5
SJM
14
-2
APD
55
3
MS
76
3
XOM
64
8
DRI
50
5
HD
35
3
LYB
20
-9
EQR
50
-3
SBUX
44
3
EQT
65
8
SLG
45
-3
NSC
64
2
HOG
45
3
MOS
26
-3
GOOG
69
2
PFE
50
2
BLK
61
6
ETR
57
5
PFG
67
2
DE
48
5
SJM
14
-2
APD
55
3
MS
76
3
XOM
64
8
DRI
50
5
Financhill
Back

Crinetics Pharmaceuticals, Inc. 10K Form

Buy
54

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$47.39
Seasonality Move:
-5.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CRNX News And Ratings

See the #1 stock for the next 7 days that we like better than CRNX

CRNX Financial Statistics

Sales & Book Value

Annual Sales: $1M
Cash Flow: $-111.6M
Price / Cash Flow: 0
Annual Sales: $11.34
Price / Book: 4.16

Profitability

EPS (TTM): -4.53400
Net Income (TTM): $-423.1M
Gross Margin: $-1.7M
Return on Equity: -37.41%
Return on Assets: -32.49%

Crinetics Pharmaceuticals, Inc. Earnings Forecast

Key Crinetics Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 9 years for CRNX is -168.05%.
  • The Selling, General & Administrative Expenses for CRNX have been equal to 9,599.33% of Gross Profit Margin.
  • The Research & Development expenses have been 22,846.10% of Revenue.
  • The Net Earning history of CRNX is -28,720.69% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 2 years.

Crinetics Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CRNX
CUSIP: 22663K
Website: crinetics.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 15.12
Quick Ratio: 14.74

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CRNX Technical Analysis vs Fundamental Analysis

Buy
54
Crinetics Pharmaceuticals, Inc. (CRNX) is a Buy

Is Crinetics Pharmaceuticals, Inc. a Buy or a Sell?